During an asthma exacerbation and in the case of uncontrolled asthma, the airway environment becomes more acidic and oxidizing that leads to the release of NO from S-nitrosoglutathione (GSN), which leads to high levels of exhaled NO [2]
These groundbreaking medications, initially approved for patients with type 2 diabetes, are now revolutionizing chronic disease treatment through their metabolic, hormonal, and anti-inflammatory effects, becoming vital tools in addressing conditions like cardiovascular disease, non-alcoholic fatty liver disease, osteoarthritis, and more.
by decreasing immobility time in the forced swim test [54]
It acts as a selective agonist at the ghrelin receptor (growth hormone secretagogue receptor type 1a, GHS-R1a), the same receptor targeted by the endogenous hormone ghrelin, to stimulate the release of growth hormone (GH) from the anterior pituitary in preclinical models